These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33205940)

  • 41. Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.
    Wan X; Zheng X; Pang X; Pang Z; Zhao J; Zhang Z; Jiang T; Xu W; Zhang Q; Jiang X
    Oncotarget; 2016 Jun; 7(23):34038-51. PubMed ID: 27086917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene.
    Yan Y; Li XQ; Duan JL; Bao CJ; Cui YN; Su ZB; Xu JR; Luo Q; Chen M; Xie Y; Lu WL
    Int J Nanomedicine; 2019; 14():3645-3667. PubMed ID: 31190817
    [No Abstract]   [Full Text] [Related]  

  • 43. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifunctional DNAzyme-Anchored Metal-Organic Framework for Efficient Suppression of Tumor Metastasis.
    Zhao Y; Li R; Sun J; Zou Z; Wang F; Liu X
    ACS Nano; 2022 Apr; 16(4):5404-5417. PubMed ID: 35384646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
    Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
    Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.
    Ding Y; Su S; Zhang R; Shao L; Zhang Y; Wang B; Li Y; Chen L; Yu Q; Wu Y; Nie G
    Biomaterials; 2017 Jan; 113():243-252. PubMed ID: 27829203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNAzyme-adsorbed polydopamine@MnO
    Xi Y; Xie X; Peng Y; Liu P; Ding J; Zhou W
    Nanoscale; 2021 Mar; 13(9):5125-5135. PubMed ID: 33651054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Codelivery of anti-cancer agents via double-walled polymeric microparticles/injectable hydrogel: A promising approach for treatment of triple negative breast cancer.
    Davoodi P; Ng WC; Srinivasan MP; Wang CH
    Biotechnol Bioeng; 2017 Dec; 114(12):2931-2946. PubMed ID: 28832946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
    Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
    [TBL] [